In addition, epigenetic studies showed promoter hypermethilation and silencing of PTX3 expression in selected human tumors, such as colorectal cancer and esophageal squamous cell carcinoma (9, 30, 36–38). The gene discussed is PTX3; the disease is esophageal squamous cell carcinoma.